18.06.2013
•
Views
Exhibition Floor Plan - First Floor 41
Exhibitors Listing AdGeniX Stand number: 780 E-mail: adgenix@adgenix.fr AdGeniX and Digital Scientific distribute the image analysis workstations for FISH, CGH and karyotyping developed by Digital Scientific. AdGeniX also offers a new prenatal screening test produced by NTD laboratories in New York for the detection of Down’s syndrome during the first trimester of pregnancy. AdGeniX distributes Vysis. Co-exhibitor: Digital Scientific Affymetrix, Inc. Stand number: 330 E-mail: gareth_thomson@affymetrix.com Website: www.affymetrix.com Affymetrix® GeneChip® microarray technology makes it possible to efficiently and reliably generate, manage and analyze large amounts of high-quality genetic information. Catalog products are currently offered for the human, rat, yeast, mouse, drosophila, arabidopsis and E. coli genomes. A flexible, affordable, custom array program is also available. Perform large-scale gene expression monitoring and genotyping experiments with a complete solution including Affymetrix GeneChip probe arrays, dynamic software, instrumentation and reagents. Agilent Technologies Stand number: 620 Website: www.agilent.com Agilent Technologies is a high-growth technology company committed to accelerating the pace of disease and drug discovery. Agilent develops and commercialises established or new technologies that greatly enhance the productivity of life science research. Agilent is the leader in several key measurement technologies used as life science tools, including liquid chromatography, mass spectrometry, and more recently microfluidics and DNA microarrays. For more information visit Agilent’s dedicated websites at: Bioanalyzer: www.agilent.com/ labonachip; Microarrays: www.agilent.com/chem/ dna; Gene Expression www.agilent.com/chem/ geneexpression. AGOWA Gesellschaft für molekularbiologische Technologie mbH Stand number: 410 E-mail: service@agowa.de Website: www.agowa.de 42 AGOWA provides genomics services that range from library construction, DNA sequencing to fully annotated sequences. The company provides a cost-effective total sequence analysis of genes that cause human diseases to detect point mutations, polymorphisms or SNPs. The isolation of DNA using conventional methods is increasingly proving to be a limiting and time-consuming factor. AGOWA continues to focus on fully automated solutions for multiple applications in routine and research based on its magnetic bead technology. Ambion (Europe) Ltd. Stand number: 700 E-mail: eurotech@ambion.com Website: www.ambion.com Ambion “The RNA Company”, founded in 1988, develops, manufactures and markets innovative products and specialty reagents for scientists whose research involves RNA or RNA analysis, including gene and tissue arrays. Ambion’s range of products includes: MessageAMP, for >1000x RNA amplification for Array Analysis; Silencer siRNA construction kit, for making siRNAs; RNAqueous- 96, for high throughput aqueous RNA isolation; Cells-tocDNA, for Reverse Transcription without RNA isolation; and many more. Please see our stand for details. Amersham Biosciences Europe GmbH Stand number: 100 Website: www.amershambiosciences.com Our biotechnology systems (instruments, reagents and software) products and services are used to uncover the function of genes and proteins, for the discovery and development of drugs and for the manufacture of biopharmaceuticals. Our scientists are constantly seeking out new ideas that will reduce the time, risk and cost of these activities. We have a strong track record in bringing scientific innovation successfully to market and significant breadth in our technology portfolio. Applied Biosystems Stand number: 190 E-mail: abdirect@eur.appliedbiosystems.com Website: www.appliedbiosystems.com Applied Biosystems is the leading supplier of life science technologies. We develop, market and support systems consisting of instruments, reagents and software that are used in basic life science research, pharmaceutical research and development, diagnostics, forensics and food testing. With sales of over $1.6 billion in fiscal year 2001 and systems in over 30,000 laboratories in over 150 countries, Applied Biosystems has had a broad impact on the evolution of biology in the last 20 years.
-
Page 1 and 2:
The Official Journal of the Europea
-
Page 3 and 4:
Table of Contents Acknowledgements
-
Page 5 and 6:
Committees - Boards European Societ
-
Page 7 and 8:
Floor Plan of the PMC 6
-
Page 9 and 10:
Programme at a glance Saturday, May
-
Page 11 and 12:
ESHG - Scientific Programme Sunday,
-
Page 13 and 14:
ESHG - Scientific Programme Sunday,
-
Page 15 and 16:
ESHG - Scientific Programme Monday,
-
Page 17 and 18:
ESHG - Scientific Programme Tuesday
-
Page 19 and 20:
ESHG - Scientific Programme Tuesday
-
Page 21 and 22:
EAGS Annual Conference and Meeting
-
Page 23 and 24:
Satellite Meetings Saturday, May 25
-
Page 25 and 26:
EMPAG - Scientific Programme Saturd
-
Page 27 and 28:
EMPAG - Scientific Programme Sunday
-
Page 29 and 30:
EMPAG - Scientific Programme Monday
-
Page 31 and 32:
EMPAG - Scientific Information Post
-
Page 33 and 34:
General Information Language The of
-
Page 35 and 36:
Registration Fees Registration Fees
-
Page 37 and 38:
Optional Social Programme COLMAR AN
-
Page 39 and 40:
Alphabetical List of Exhibitors as
-
Page 41:
Exhibition Floor Plan - Ground Floo
-
Page 45 and 46:
Coriell Institute for Medical Resea
-
Page 47 and 48:
GMP Genetics, Inc. Stand number: 59
-
Page 49 and 50:
MWG-Biotech AG Stand number: 240 E-
-
Page 51 and 52:
Qbiogene Stand number: 510 E-mail:
-
Page 53 and 54:
Transgenomic Stand number: 280 E-ma
-
Page 55 and 56:
Plenary Sessions during the same pe
-
Page 57 and 58:
Symposia However, more than 30 year
-
Page 59 and 60:
Symposia breast and ovarian tissue
-
Page 61:
Concurrent Sessions showed strong e
-
Page 64 and 65:
Concurrent Sessions C12. Comparison
-
Page 66 and 67:
Concurrent Sessions 1INSERM U393, H
-
Page 68 and 69:
Concurrent Sessions also demonstrat
-
Page 70 and 71:
Concurrent Sessions C 7. Cancer Gen
-
Page 72 and 73:
Concurrent Sessions arisen on an an
-
Page 74 and 75:
Posters - Analysis of Disorders and
-
Page 76 and 77:
Posters - Analysis of Disorders and
-
Page 78 and 79:
Posters - Analysis of Disorders and
-
Page 80 and 81:
Posters - Analysis of Disorders and
-
Page 82 and 83:
Posters - Analysis of Disorders and
-
Page 84 and 85:
Posters - Cancer Genetics originati
-
Page 86 and 87:
Posters - Cancer Genetics the livin
-
Page 88 and 89:
Posters - Cancer Genetics which cau
-
Page 90 and 91:
Posters - Cancer Genetics had monos
-
Page 92 and 93:
Posters - Cancer Genetics and lymph
-
Page 94 and 95:
Posters - Cancer Genetics T-PL leuk
-
Page 96 and 97:
Posters - Cancer Genetics using pos
-
Page 98 and 99:
Posters - Cancer Genetics P0109. Ch
-
Page 100 and 101:
Posters - Cancer Genetics aberratio
-
Page 102 and 103:
Posters - Cancer Genetics We conclu
-
Page 104 and 105:
Posters - Cancer Genetics P0136. Le
-
Page 106 and 107:
Posters - Cancer Genetics - IVS8 -1
-
Page 108 and 109:
Posters - Cancer Genetics P0154. Me
-
Page 110 and 111:
Posters - Cancer Genetics theorized
-
Page 112 and 113:
Posters - Clinical Genetics and Dys
-
Page 114 and 115:
Posters - Clinical Genetics and Dys
-
Page 116 and 117:
Posters - Clinical Genetics and Dys
-
Page 118 and 119:
Posters - Clinical Genetics and Dys
-
Page 120 and 121:
Posters - Clinical Genetics and Dys
-
Page 122 and 123:
Posters - Clinical Genetics and Dys
-
Page 124 and 125:
Posters - Clinical Genetics and Dys
-
Page 126 and 127:
Posters - Clinical Genetics and Dys
-
Page 128 and 129:
Posters - Clinical Genetics and Dys
-
Page 130 and 131:
Posters - Clinical Genetics and Dys
-
Page 132 and 133:
Posters - Clinical Genetics and Dys
-
Page 134 and 135:
Posters - Clinical Genetics and Dys
-
Page 136 and 137:
Posters - Cystic Fibrosis, Familial
-
Page 138 and 139:
Posters - Cystic Fibrosis, Familial
-
Page 140 and 141:
Posters - Cystic Fibrosis, Familial
-
Page 142 and 143:
Posters - Cytogenetics than the ver
-
Page 144 and 145:
Posters - Cytogenetics all 46, XX T
-
Page 146 and 147:
Posters - Cytogenetics insertion of
-
Page 148 and 149:
Posters - Cytogenetics children had
-
Page 150 and 151:
Posters - Cytogenetics University C
-
Page 152 and 153:
Posters - Cytogenetics Pelvic nodal
-
Page 154 and 155:
Posters - Cytogenetics this study p
-
Page 156 and 157:
Posters - Cytogenetics dysgenesis s
-
Page 158 and 159:
Posters - Cytogenetics involving ch
-
Page 160 and 161:
Posters - Cytogenetics (q24.3; 161
-
Page 162 and 163:
Posters - Cytogenetics All the abno
-
Page 164 and 165:
Posters - Diabetes All 21 clones we
-
Page 166 and 167:
Posters - Gene Structure and Functi
-
Page 168 and 169:
Posters - Gene Structure and Functi
-
Page 170 and 171:
Posters - Gene Structure and Functi
-
Page 172 and 173:
Posters - Genetic Counselling and G
-
Page 174 and 175:
Posters - Genetic Counselling and G
-
Page 176 and 177:
Posters - Genetic Epidemiology and
-
Page 178 and 179:
Posters - Genetic Epidemiology and
-
Page 180 and 181:
Posters - Genetic Epidemiology and
-
Page 182 and 183:
Posters - Genetic Epidemiology and
-
Page 184 and 185:
Posters - Genetic Epidemiology and
-
Page 186 and 187:
Posters - Genetic Epidemiology and
-
Page 188 and 189:
Posters - Genetic Epidemiology and
-
Page 190 and 191:
Posters - Genetic Services, Genetic
-
Page 192 and 193:
Posters - Genetic Services, Genetic
-
Page 194 and 195:
Posters - Genetic Services, Genetic
-
Page 196 and 197:
Posters - Genetic Services, Genetic
-
Page 198 and 199:
Posters - Genetic Services, Genetic
-
Page 200 and 201:
Posters - Genomics and Bioinformati
-
Page 202 and 203:
Posters - Globins Assays-On-DemandT
-
Page 204 and 205:
Posters - Globins P0609. Prevention
-
Page 206 and 207:
Posters - Inborn Errors of Metaboli
-
Page 208 and 209:
Posters - Inborn Errors of Metaboli
-
Page 210 and 211:
Posters - Inborn Errors of Metaboli
-
Page 212 and 213:
Posters - Inborn Errors of Metaboli
-
Page 214 and 215:
Posters - Linkage Mapping and Polym
-
Page 216 and 217:
Posters - Linkage Mapping and Polym
-
Page 218 and 219:
Posters - Linkage Mapping and Polym
-
Page 220 and 221:
Posters - Mental Retardation by seq
-
Page 222 and 223:
Posters - Mental Retardation from l
-
Page 224 and 225:
Posters - Mental Retardation P0704.
-
Page 226 and 227:
Posters - Mental Retardation 1 Medi
-
Page 228 and 229:
Posters - Mental Retardation aberra
-
Page 230 and 231:
Posters - Mental Retardation were s
-
Page 232 and 233:
Posters - Mental Retardation into t
-
Page 234 and 235:
Posters - Mental Retardation Willia
-
Page 236 and 237:
Posters - Molecular Basis of Develo
-
Page 238 and 239:
Posters - Molecular Basis of Mendel
-
Page 240 and 241:
Posters - Molecular Basis of Mendel
-
Page 242 and 243:
Posters - Molecular Basis of Mendel
-
Page 244 and 245:
Posters - Molecular Basis of Mendel
-
Page 246 and 247:
Posters - Molecular Basis of Mendel
-
Page 248 and 249:
Posters - Molecular Basis of Mendel
-
Page 250 and 251:
Posters - Molecular Basis of Mendel
-
Page 252 and 253:
Posters - Molecular Basis of Mendel
-
Page 254 and 255:
Posters - Molecular Basis of Mendel
-
Page 256 and 257:
Posters - Muscle Diseases excluded.
-
Page 258 and 259:
Posters - Muscle Diseases ribonucle
-
Page 260 and 261:
Posters - Muscle Diseases Genotype-
-
Page 262 and 263:
Posters - Neurogenetics according t
-
Page 264 and 265:
Posters - Neurogenetics causing deg
-
Page 266 and 267:
Posters - Neurogenetics pigmentosa
-
Page 268 and 269:
Posters - Neurogenetics P0909. BACE
-
Page 270 and 271:
Posters - Neurogenetics and periphe
-
Page 272 and 273:
Posters - Neurogenetics Research Co
-
Page 274 and 275:
Posters - Neurogenetics 1 IGBMC - C
-
Page 276 and 277:
Posters - Prenatal and Perinatal Ge
-
Page 278 and 279:
Posters - Prenatal and Perinatal Ge
-
Page 280 and 281:
Posters - Prenatal and Perinatal Ge
-
Page 282 and 283:
Posters - Prenatal and Perinatal Ge
-
Page 284 and 285:
Posters - Prenatal and Perinatal Ge
-
Page 286 and 287:
Posters - Prenatal and Perinatal Ge
-
Page 288 and 289:
Posters - Sensory Genetics a new lo
-
Page 291 and 292:
Posters - Sensory Genetics 70% of a
-
Page 293 and 294:
Posters - Techniques for Mutation D
-
Page 295 and 296:
Posters - Techniques for Mutation D
-
Page 297 and 298:
Posters - Techniques for Mutation D
-
Page 299 and 300:
Posters - Techniques for Mutation D
-
Page 301 and 302:
Posters - Therapy for Genetic Disor
-
Page 303 and 304:
Posters - Y chromosome, Infertility
-
Page 305 and 306:
Posters - Y chromosome, Infertility
-
Page 307 and 308:
EMPAG Plenary Sessions EMPAG Abstra
-
Page 309 and 310:
EMPAG Concurrent Sessions case hist
-
Page 311 and 312:
EMPAG Concurrent Sessions E-C06. Br
-
Page 313 and 314:
EMPAG Concurrent Sessions E-C16. Th
-
Page 315 and 316:
EMPAG Concurrent Sessions those ind
-
Page 317 and 318:
EMPAG Posters E-P03. The situation
-
Page 319 and 320:
EMPAG Posters should provides famil
-
Page 321 and 322:
EMPAG Posters E-P22. Predictive med
-
Page 323 and 324:
EMPAG Posters general response (84%
-
Page 325 and 326:
EMPAG Posters aspects of care durin
-
Page 327 and 328:
EMPAG Posters boredom or interests
-
Page 329 and 330:
Author Index Bacolla, A. P0453 Baco
-
Page 331 and 332:
Author Index 330 Carranza-Lira, S.
-
Page 333 and 334:
Author Index 332 Dmitriev, M. P0577
-
Page 335 and 336:
Author Index 334 Gigola, L. E-C23 G
-
Page 337 and 338:
Author Index 336 E-C13 Jacquemont,
-
Page 339 and 340:
Author Index 338 Lasa, A. P0155, P0
-
Page 341 and 342:
Author Index 340 Mestroni, L. P0864
-
Page 343 and 344:
Author Index 342 Pavelic, J. P0866
-
Page 345 and 346:
Author Index 344 Rubinsztein, D. C.
-
Page 347 and 348:
Author Index 346 Stoetzel, C. P0209
-
Page 349 and 350:
Author Index 348 P0401 Vogt, P. C03
-
Page 351 and 352:
Notes 350
-
Page 353 and 354:
Keyword Index 352 beta catenin: P00
-
Page 355 and 356:
Keyword Index 354 Double minute: P0
-
Page 357 and 358:
Keyword Index 356 imprinting: P0184
-
Page 359 and 360:
Keyword Index 358 oro-facio-digital
-
Page 361:
Keyword Index 360 Survival motor ne